Cell-based therapy approaches using dying cells: from tumour immunotherapy to transplantation tolerance induction.
Cell-based therapies are promising approaches to treat uncontrolled pathologies, such as tumours. Apoptotic tumour cells have recently been proposed as a source of tumour-associated antigens to stimulate an efficient immune response. However, a complex relationship exists between apoptosis and the immune system. In this review, the different factors that may influence immune responses against apoptotic cells are detailed and discussed in the light of recent publications. These factors include the nature of the phagocytes and the receptors involved in apoptotic cell uptake, as well as the environment in which cells are dying. A possible distinction between apoptosis and necrosis by immune system sentinels adds a further level of complexity. The potential use of the immunomodulatory properties associated with apoptosis to favour engraftment and induce tolerance in transplantation is then discussed. In conclusion, this review will suggest appropriate conditions to efficiently and safely use apoptotic cells as a new cell therapy product.
Saas
Philippe
P
INSERM E0119/UPRES EA2284, Etablissement Fran ais du Sang de Bourgogne Franche-Comt , 1 Boulevard A. Fleming, BP1937, F-25020 Besan on, France. philippe.saas@efs.sante.fr
Tiberghien
Pierre
P
de Carvalho Bittencourt
Marcelo
M
D000818:Animals; D017209:Apoptosis; D006801:Humans; D007108:Immune Tolerance; D007111:Immunity, Cellular / Q000276:immunology; D007167:Immunotherapy / Q000379:methods*; D016219:Immunotherapy, Adoptive / Q000379:methods*; D014611:Vaccination